In this study, taking advantage of a panel of in situ hybridization (ISH) probes targeting the marker genes for different stages of OL lineage cells, including Pdgfra, Plp, Mbp, Mog, and especially the recently reported maker gene for newly forming OLs, namely Enpp6 , with the combination of immunofluorescence staining of CC1, SOX10, we provide a temporally detailed dynamic profile of OL lineage cells in the currently most commonly used standardized acute CPZ demyelination model of 5 weeks feeding followed by 4 weeks recovery
Ul Hasan A, Rahman A, Kobori H
Key regulatory points for Epitalon Australia compliance: Epitalon is not approved by the Therapeutic Goods Administration (TGA) as a registered medicine for human or veterinary use It is classified strictly for laboratory and research purposes, not for human consumption Supply, import, and handling of research peptides fall under Australian regulatory oversight, and institutions should confirm current scheduling status directly through TGA resources before procurement Any research involving human subjects must comply with Research Ethics Committee approval and applicable Good Clinical Practice standards Marketing or supplying Epitalon with therapeutic claims, or implying suitability for human treatment, falls outside permitted research-use classifications Researchers and institutions should treat Epitalon strictly as a laboratory reagent, ensuring internal documentation, handling protocols, and communications consistently reflect its research-only status

Hence, addressing underlying self-consciousness distortions is important part of the therapy of body image disorders.